Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results matching your filters

Azacytidine, Venetoclax Plus Minus Quizartinib for First Line Older/Unfit AML Patients (VENP-A-QUI)Recruiting
NCT07478991Phase 3Updated Aug 17, 2026
Sponsor: PETHEMA Foundation
Acute Myeloid Leukemia, Adult
Spain
Clinical Study to Evaluate the Efficacy and Safety of Huperzine A Controlled-Release Tablets in Patients With Mild-to-Moderate Dementia of the Alzheimer's TypeRecruiting
NCT07066826Phase 2, Phase 3Updated Aug 17, 2026
Sponsor: Wanbangde Pharmaceutical Group Co., LTD
Alzheimer Dementia
China
Limited Versus Extended Trophic Feeding (LET-FEED) TrialRecruiting
NCT06893939Phase 2, Phase 3Updated Aug 17, 2026
Sponsor: University of Washington
Sepsis · Length of Stay · Mortality · Neurodevelopmental Delay
United States
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial CancerRecruiting
NCT07166094Phase 3Updated Aug 17, 2026
Sponsor: Genmab
Endometrial Cancer · Recurrent or Progressive Endometrial Cancer
United States, Australia, Belgium, Brazil, Canada +14 more
A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic LeukemiaRecruiting
NCT07223021Phase 3Updated Aug 17, 2026
Sponsor: Memorial Sloan Kettering Cancer Center
B-cell Acute Lymphoblastic Leukemia
United States
HYDROchlorothiazide to PROTECT Polycystic Kidney Disease Patients and Improve Their Quality of LifeRecruiting
NCT05373264Phase 3Updated Aug 14, 2026
Sponsor: University Medical Center Groningen
ADPKD
Belgium, France, Germany, Netherlands, Spain +1 more
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric ParticipantsRecruiting
NCT05835310Phase 3Updated Aug 14, 2026
Sponsor: AstraZeneca
Systemic Lupus Erythematosus
United States, Argentina, Brazil, Canada, China +12 more
A Study to Investigate NPS and Symptoms in Chinese Adult Participants With CRSwNP Initiating Treatment With TezepelumabRecruiting
NCT07520162Phase 3Updated Aug 14, 2026
Sponsor: AstraZeneca
Chronic Rhinosinusitis With Nasal Polyps
China
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian CancerRecruiting
NCT06072781Phase 3Updated Aug 14, 2026
Sponsor: Verastem, Inc.
Low Grade Serous Ovarian Cancer
United States, Australia, Belgium, Canada, Denmark +11 more
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe DiseaseRecruiting
NCT06679140Phase 3Updated Aug 14, 2026
Sponsor: Pfizer
COVID-19 SARS-CoV-2 Infection
United States, Argentina, Belgium, Brazil, Bulgaria +14 more
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)Recruiting
NCT07179380Phase 3Updated Aug 14, 2026
Sponsor: Insmed Incorporated
Pulmonary Hypertension · Interstitial Lung Disease
United States, Argentina, Australia, Austria, Belgium +22 more
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other TreatmentsRecruiting
NCT05020236Phase 3Updated Aug 14, 2026
Sponsor: Pfizer
Multiple Myeloma
United States, Argentina, Australia, Austria, Belgium +21 more
A Safety and Efficacy Study of hu14 in High-Risk Neuroblastoma PatientsRecruiting
NCT07549321Phase 2, Phase 3Updated Aug 14, 2026
Sponsor: Renaissance Pharma Ltd.
High-Risk Neuroblastoma
United States, Canada
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCTRecruiting
NCT07764978Phase 3Updated Aug 14, 2026
Sponsor: AstraZeneca
Newly Diagnosed Multiple Myeloma
United States, Australia, Brazil, Canada, Denmark +10 more
A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically SuppressedRecruiting
NCT07650916Phase 3Updated Aug 14, 2026
Sponsor: ViiV Healthcare
HIV Infections
United States, Argentina, Australia, Canada, Japan +4 more
A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 GangliosidosisRecruiting
NCT07054515Phase 3Updated Aug 14, 2026
Sponsor: Azafaros B.V.
Niemann-Pick Type C Disease · GM1 Gangliosidosis · GM2 Gangliosidosis
United States, Argentina, Australia, Brazil, Canada +12 more
A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)Recruiting
NCT07044297Phase 3Updated Aug 14, 2026
Sponsor: Merck Sharp & Dohme LLC
Human Immunodeficiency Virus (HIV) · HIV Pre-Exposure Prophylaxis
United States, Argentina, Brazil, Chile, Colombia +11 more
Phase III Study to Compare GFH375 and Chemotherapy in Patients With KRAS G12D-Mutant Metastatic Pancreatic CancerRecruiting
NCT07262567Phase 3Updated Aug 14, 2026
Sponsor: Genfleet Therapeutics (Shanghai) Inc.
Metastatic Pancreatic Cancer
China
An Extension Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer in ChinaRecruiting
NCT07604766Phase 3Updated Aug 14, 2026
Sponsor: Genmab
Platinum-resistant Ovarian Cancer
China
A Study of Mezagitamab in Adults With Kidney Condition Called IgA NephropathyRecruiting
NCT06963827Phase 3Updated Aug 14, 2026
Sponsor: Takeda
Kidney Disease
United States, Argentina, Australia, Austria, Canada +21 more
Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.Recruiting
NCT05609630Phase 3Updated Aug 14, 2026
Sponsor: AbbVie
Juvenile Idiopathic Arthritis
United States, Argentina, Australia, Austria, Brazil +12 more
A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)Recruiting
NCT07570173Phase 2, Phase 3Updated Aug 14, 2026
Sponsor: Merck Sharp & Dohme LLC
B-cell Acute Lymphoblastic Leukemia
Denmark, Greece, Israel, Italy, Japan +2 more
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)Recruiting
NCT07007065Phase 3Updated Aug 14, 2026
Sponsor: AbbVie
Neovascular Age-related Macular Degeneration
United States, Austria, Belgium, Bulgaria, Canada +12 more
A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)Recruiting
NCT07489495Phase 3Updated Aug 14, 2026
Sponsor: Merck Sharp & Dohme LLC
Carcinoma, Renal Cell
United States, Argentina, Australia, Brazil, Chile +13 more
Low-Intensity Extracorporeal Shockwave Therapy on Penile Rehabilitation After Robot-assisted Surgical Treatment of Genitourinary CancersRecruiting
NCT06717711Phase 3Updated Aug 14, 2026
Sponsor: Regina Elena Cancer Institute
Prostate Carcinoma · Erectile Function · Genito Urinary Cancer
Italy

Previous page Next page